Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100046479Phase 4Recruiting
Phase 4, randomised, double-blind trial of esketamine and sevoflurane (2 arms), sponsored by Xijing Hospital. Primary endpoint: Emergence time of sevoflurane anesthesia. Started Apr 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100046479.